Therapeutic equivalence of the generic and the reference atorvastatin in patients with increased coronary risk

Abstract

Both the generic and the reference atorvastatin were equally effective in correcting the lipid profile and reducing calculated absolute coronary risk in patients with hyperlipidemia and increased coronary risk. Both treatments were equally well tolerated.

Keywords

• Risk assessment
• lipids
• statins
• essential-hypertension
• primary hypercholesterolemia
• artery-disease
• blood-pressure